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Abstract
Background: Our aim is to detect the infection by Toscana virus (TOSV) and other Phleboviruses in the sera and
cerebro-spinal fluid (CSF) of patients with meningitis in Tunisia. We examined various species of phlebotomus
present in Tunisia to determine whether or not a direct relationship exists between cases of meningitis and the
viruses circulating in the insect vectors.
Methods: Patients with the meningeal syndrome were tested for anti-TOSV IgM and IgG using an indirect
Enzyme-Linked Immunosorbent Assay (ELISA) and for the presence of TOSV and other Phleboviruses using a
RT-PCR test.
An entomological study was carried out using CDC light traps to trap sandflies in different bioclimatic zones of Tunisia.
Collected sandflies were tested by RT-PCR for the presence of TOSV and other Phleboviruses and subsequently by viral
isolation on Vero cells.
Results: Of 263 patients were tested using ELISA of which 12.16% (n = 32/263) were IgM positive for anti TOSV. Of
these 32 patients, 78% (n = 25/32) were IgG positive. 12.86% (n = 18/140) of the CSF samples tested by RT-PCR were
positive for the Toscana virus.
One CSF sample tested by RT-PCR revealed the presence of Sandfly Fever Sicilian Virus (SFSV). The Punique virus was
identified in one sandfly pool.
Conclusions: This study confirms, for the first time, that TOSV is involved in a neurological disorder in North
Africa. The incidence of this involvement in Tunisia conforms with observations made in other Mediterranean
countries. Moreover, for the first time, a molecular approach was used to detect SFSV in a Tunisian patient
displaying neurological symptoms.
Keywords: Toscana virus, ELISA, Nested RT-PCR, Viral isolation, Sandfly Fever Sicilian virus, Punique virus, Phlebovirus,
Sandflies, Phlebotomus, Tunisia
Background
The Toscana virus (TOSV) is an arthropodborne phle-
bovirus of the Bunyaviridae family that is endemic in
Mediterranean countries where the insect vectors Phle-
botomus perniciosus and P. perfiliewi are present [1].
TOSV is involved in acute neurological diseases in
humans, particularly during the summer. Disease inci-
dence peaks in August, which correlates with the life cycle
of the phlebotomus vectors [2] that play a role in transmit-
ting the virus [3].
Reports have been made of TOSV infection associated
with aseptic meningitis, meningoencephalitis (AMM), or
with encephalitis without meningitis [4,5]. Some unusual
cases of AMM were described in Italy and Spain [6,7].
Asymptomatic infections and infections that do not affect
the central nervous system, such as febrile erythema or
influenza-like illnesses, have also been described [8].
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Consequently, it is not possible to define a characteristic
symptomatology for neurological infections from TOSV
[9]. To date, no reinfections have been detected and pre-
existing immunity plays a role in limiting the disease in
areas where TOSV is prevalent currently [10,11]. The
mean duration of the disease is seven days. The outcome
is usually favorable [3].
TOSV has a segmented RNA genome composed of 3
units: L (large), M (medium), and S (small) encoding the
viral proteins [12-14]. A phylogenetic analysis has dem-
onstrated that TOSV isolates from Spain differ from the
original isolates from Italy; two clusters have been iden-
tified as lineage A (Italy) and lineage B (Spain) [15]. A
new lineage C has been described in both Croatia and
Greece [16,17]. The obtained nucleotide sequence showed
a homology that is similar to the TOSV sequences from
the A and B lineages (75%–82%) although it clusters with
neither.
The well-known difficulty of directly diagnosing acute
viral neurological infections is due to a short viremic
phase with a low viral load during clinical symptom-
atology that generally corresponds to the period of
hospitalization and clinical sampling [18]. The virus can,
however, be isolated from cerebrospinal fluid (CSF) and/or
serum if it is collected during the acute phase of the dis-
ease. TOSV replicates in Vero, BHK-21, CV-1, and SW13
cells with cytopathic effect [19].
A study conducted in Morocco showed the presence
of TOSV in the sandfly vectors; however no data on hu-
man epidemiology were published [20]. In Tunisia, the
epidemiology of the TOSV infection remains largely un-
known, despite the availability of reliable diagnostic la-
boratory tools and epidemiological surveillance. A few
recent studies have reported that 10% of the patients
(n = 31) with meningeal syndrome had specific IgM against
TOSV [21]. A serological survey using an ELISA test
showed a 9.5% seroprevalence of TOSV among healthy
individuals [22]. In a recent letter, Bichaud et al. [23] ac-
knowledged finding that two Phleboviruses – the TOSV
and the Punique virus – co-circulate in sand flies collected
in Tunisia but no definitive evidence of a TOSV infection
in aseptic meningitis infections was found.
The objective of this work was to detect infection by
TOSV and other Phleboviruses in the sera and cerebo-
spinal fluid of subjects with meningitis during the summer.
We examined various phlebotomus species circulating in
Tunisia to prove the existence of a direct relationship




Between June 2011 and November 2012, 331 patients
with meningeal syndrome (symptoms include acute fever,
headaches, and the presence of more than 10 CSF white
blood cells per mm3) from different regions of Tunisia
(Tunis in the north, Bizerte to the west, Monastir to the
southeast, Sousse along the northeastern coast, Sfax along
the southeastern coast and Gabes in the south) were ad-
mitted to Tunisian hospitals. Bacterial and fungal cultures
of CSF samples tested negative. Suspecting a viral aetiology,
the clinical virology laboratory of the Pasteur Institute of
Tunis systematically searched for enteroviruses, herpes
simplex virus, and West Nile virus, but the analysis proved
negative. Samples (sera and CSF) collected from the 331
patients were examined for TOSV or other Phleboviruses
infection.
Informed consent from the patient’s participants to
this study was obtained. This study was approved by The
Bioethics Committee of the Institut Pasteur de Tunis.
Serological investigation
The 191 sera and 72 CSF samples collected were tested
in duplicate for the presence of TOSV-specific IgM and
IgG antibodies using an indirect in-house ELISA. Wells
of polystyrene plates were coated with a predetermined
optimum quantity of positive and negative antigens pre-
pared on a Vero cell culture infected by the reference
strain ISS Phl3 kindly provided by the Bunyaviridae
Laboratory (Professor Bouloy, Institut Pasteur de Paris), in
phosphate-buffered saline (PBS) (pH 7.2) and incubated
overnight at 4°C. Human sera were diluted at 1:100 in
PBS–TM (PBS, 0.05% Tween 20, 3% milk). Each assay in-
cluded two negative and two positive control sera. Goat
anti-human IgM and Goat anti-human IgG (Fc-specific)
peroxidase conjugated antibody (Sigma-Aldrich, Germany)
was diluted at 1:1000 for sera and at 1/10 for CSF and
added to each well. A color reaction was developed by add-
ing a substrate solution containing 3,3′,5,5′-tetramethyl-
benzidine (TMB) (Sigma-Aldrich, Germany). The reaction
mixture was incubated for 75 min. at 37°C at each step,
and washed extensively with PBS–Tween. H2SO4 was
added at a final concentration of 1 N to stop the reaction.
All serum samples were tested in duplicate with viral and
negative control antigens [21,22]. The IgM and IgG ELISA
cut-off values were determined by the mean +3 standard
deviations of the read optical density. The borderline value
was calculated as the mean value of 30 known negative
sera plus 3 standard deviations. The OD of each sample
was read at a double wavelength of 450 nm and 620 nm.
Molecular investigation
Detection of TOSV and other Phleboviruses in CSF samples
RNA extraction and RT-PCR: RNA extraction was per-
formed using the NucleoSpin RNA II kit (Macherey
Nagel, Germany) following the manufacturer’s instructions.
Eluted RNA was collected and stored at −80°C when not
immediately used.
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RT-PCR and nested PCR were performed using degen-
erated primer pairs specific for TOSV L genomic seg-
ment as described by Sanchez-Seco et al. [24] with some
modifications. To avoid any risk of contamination, 6 μL
of RNA were used in a one-step RT-PCR reaction with
NPhlebo1+/NPhlebo1- primers rather than the two-step
protocol described elsewhere. Two different nested PCR
reactions were performed in parallel using the degener-
ated NPhlebo2+/NPhlebo2- primers, suitable for detecting
Toscana, Naples, Sicilian, Rift Valley fever, Uukuniemi and
Punta Toro viruses, and the Atos2/NPhlebo2+ primers for
the specific detection of the TOSV [24]. Several measures
were taken to avoid possible contamination, including es-
tablishing separate spaces to set up PCRs, filter tips and
UV radiations. In addition, tests were run on only a few
samples at the same time. Different negative controls (no
DNA, uninfected sample and extracted no DNA) were
used. A viral extract (culture of TOSV, ISS Phl.3 strain)
generously provided by Dr. M.G. Cusi, was used as a posi-
tive control.
Detection of TOSV and other Phleboviruses in sandflies
Capture of phlebotomine sandflies: Using CDC light traps
(John W. Hock Company, Gainesville, FL, USA), phleboto-
mine sandflies were captured after dusk and until dawn
from June to November (2011 and 2012), the period and
time when they are active in Tunisia, in the regions where
patients showed clinical AMM (Figure 1). Once trapped,
the sandflies were immediately stored in liquid nitrogen.
Pooling and RNA extraction
Stored sandflies were separated into pools of males and
females. The males were preserved in alcohol for later
identification whereas the females, which are hema-
tophagous, were prepared for viral molecular identifica-
tion. For this purpose, the head and genitalia of each
female were cut for taxonomic diagnosis as per Croset
et al. [25], while the thorax (which encloses the salivary
glands) and abdomen were used for RNA extraction.
Once the taxonomic work had been carried out, pools
were made of a maximum of 30 abdomens of females of
the same species captured during the same period from
the same capture site.
Each pool was ground in 350 μl of 3% fetal bovine serum
(FBS, Sigma-Aldrich, Germany) enriched phosphate-
buffered saline (PBS). Two hundred μl of ground solution
were used for total RNA purification with the RNeasy Plus
Mini kit (Qiagen, Germany) as per the manufacturer’s in-
structions. RT-nested PCR was performed to detect TOSV
in sandflies as described above.
Viral isolation
Viral isolation on Vero cells (ATCC CCL-81) was per-
formed on some PCR-positive sandfly pools, as described
by Sanchez-Seco et al. [24], with minor modifications: Vero
cells were grown in Dulbecco’s Modified Eagle Medium
(DMEM) (Lonza, Milan, Italy), supplemented with 2%
FBS (Lonza, Milan, Italy) and 0.01% penicillin and strepto-
mycin (Lonza, Milan, Italy), as a monolayer in 96 wells
plate. Fifty μl of ground sandfly pools were used to infect
the monolayers, after which 100 μl of DMEM without
FBS were added. Cultures were maintained and moni-
tored daily for 7–15 days until a cytopatic effect (CPE)
became evident. Positive cultures were expanded on
Vero cells and cell-culture supernatants were stored in
aliquots at −80°C.
Sequencing and data analysis
Specific TOSV detection was carried out by sequencing
PCR products as described previously [24]. The PCR
products were purified using the ExoSAP cleanup proced-
ure (Amersham Biosciences, France). All nucleotide se-
quences were obtained using the Big Dye Terminator v.3.1
Cycle Sequencing Kit (Applied Biosystems, Foster City,
CA, USA) and the 3130 automated sequencer (Applied
Biosystems, Foster City, CA, USA). Sequences were edited
and aligned using DNA Baser Sequence Aligner v3.5.4
software (Heracle BioSoft SRL, www.DnaBaser.com) to ob-
tain optimal sequence alignment files. A BLAST analysis at
the NCBI database was made to retrieve sets of homo-
logues exhibiting high scores to the L gene of TOSV.
To build phylogenetic tree, the maximum parsimony
[26] method calculating bootstrap confidence values of
100 bootstrapping trials, using the MEGA 5.2 software,
was used.
Statistical analyses
Statistical differences among the groups were determined
using Pearson’s Chi-square test. To calculate the Chi2, the
Epi Info v.6.04 was used. A probability (P) value of less
than 0.05 was considered statistically significant.
Nucleotide sequence accession numbers
The sequences generated in this study have been depos-
ited in the DNA Data Bank of Japan (DDBJ) under




From the 331 patients (1–81 years old), 140 CSF sam-
ples (88 men, 52 women) and 191 sera (112 men, 79
women) were tested for Phlebovirus infection. CSF sam-
ples (n = 72) were tested by both PCR and enzymatic im-
munoassay (ELISA) to detect specific IgM. The remaining
(n = 68) were tested only by PCR because only limited
amount of materials were available from sera reactive indi-
viduals. All 191 sera were tested using ELISA.
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Figure 1 Map of Tunisia indicating sandflies capture sites and human AMM cases.
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IgM/IgG antibodies against TOSV
The presence of TOSV-specific IgM was investigated in
the 263 sera and CSF samples collected from patients
admitted with AMM to various hospitals in Tunisia. Of
these, 12.16% (CI95% [8.47%–16.74%]) tested positive
for anti-TOSV IgM: the prevalence of TOSV IgM was
detected in 13.6% (26/191) of the serum samples and
8.3% (6/72) of the CSF samples. The different rates
detected in sera and CSF samples were not significant
(p = 0.24). Geographically, most positive samples came
from Tunis (n = 10), Mahdia (n = 7) and Bizerte (n = 6)
while the balance (n = 9) came from ten other governor-
ates (Figure 1). The anti-TOSV IgM positive samples were
also tested for the presence of IgG antibodies against
TOSV. Among them, 25 (78%) were IgG positive. Unfor-
tunately, we were unable to obtain a second serum sample
from patients that would have allowed us to follow the
antibodies titres.
Molecular investigation
Detection of TOSV and other Phleboviruses in CSF samples
Of the 140 CSF samples tested by RT-PCR, 18 (12.86%,
CI95% [7.80%–19.56%]) were positive with both phlebovirus-
generic and TOSV-specific primer sets. The TOSV-
positive samples (14 men, 4 women) were from Tunis
(n = 14), Bizerte (n = 2), Mahdia (n = 1) and Sfax (n = 1).
Moreover, one sample was sequenced that had tested posi-
tive with the NPhlebo2 pair of primers but negative with
the specific TOSV primers Atos2. Of the samples tested,
72 CSF samples were investigated by both RT-PCR and
ELISA: two of these samples (2.7%) had antibodies reactive
to the TOSV antigen, six of the 72 CSF samples (8.3%)
were positive by PCR and negative by ELISA, one (1.3%)
was negative by nested PCR and positive by ELISA for
anti-TOSV IgM and IgG, while 63 (87.5%) were negative
by both methods.
Detection of TOSV and other Phleboviruses in sandflies
Between 2011 and 2012, a total of 8040 sandflies were
collected by CDC light traps. Of these, 2000 males and
1050 females underwent taxonomic identification that
made it possible to diagnose 14 species (Table 1). The
remaining sandflies were conserved at −80°C for subse-
quent studies.
The female pools were subjected to RNA extraction
for RT-PCR detection of Phleboviruses. Of the 39 pools
tested, 14 were positive with phlebovirus-generic primers.
Among them, 13 were positive with TOSV-specific primer
sets: 8 positive pools of P. perniciosus and 5 of P. perfiliewi.
A single pool tested positive with the NPhlebo2 primers
but not with the TOSV specific primers. The positive pools
of sandflies had all been collected in 5 governorates lo-
cated in Tunisia’s sub-humid, semi-arid and arid biocli-
matic zones (Table 1).
No virus was detected in the other Phlebotomus and
Sergentomya species that were tested.
Sequencing and culture results
A total of 31 samples (19 CSF samples, 12 sandfly pools)
were sequenced using primers specific for Phlebovirus
(NPhlebo2) and TOSV (ATos2).
Of the 19 CSF-derived amplicons that were sequenced:
– 15 sequences (from 120–180 sequenced nt) were
obtained with Atos2 set primers [DDBJ: AB904897
to AB904911] and three sequences (from 200–250
sequenced nt) were obtained with NPhlebo2 set
primers [DDBJ: AB904918, AB904919, AB905360]
The BLAST analysis on the National Center for
Biotechnology Information website retrieved a
unique hit consisting of the TOSV polymerase gene
with a 98–99% identity score with French
[GenBank: DQ975233, KC700343], 95–97% with
Moroccan [GenBank:JN832571] and 95% with
Tunisian [GenBank:JX867537] strains of TOSV.
– Only one CSF-derived amplicon sequenced [DDBJ:
AB905361] was similar (98%) to the published
sequence of the Sandfly Fever Sicilian Virus (SFSV)
[GenBank: EF095551] derived from sandflies collected
in Algeria [27].
Of the 12 pool-derived amplicons that were sequenced:
– Six sequences [DDBJ: from AB904912 to AB904917]
and five sequences were obtained with NPhlebo2 set
primers [DDBJ: from AB904920 to AB904924]. The
BLAST analysis revealed 98–99% identity with French
[GenBank: DQ975233, KC700343] and 95–97% with
Moroccan [GenBank: JN832571] TOSV strains.
– In an effort to isolate the virus for more significant
sequence information, we randomly selected eight
pools, including those that were positive with only
the Nphlebo2 primer set, and seeded them onto
Vero cells to grow the virus. Only a single sample
showed a marked cytopathic effect after eight days.
The BLAST of culture-derived PCR product [DDBJ:
AB905362] was strongly homologous (95%) with
the Punique virus strain PI-B4-2008 [GenBank:
JF920133] from Tunisia.
Phylogenetic analysis
In a maximum parsimony analysis based on the align-
ment of the L segment of TOSV, a phylogenetic tree was
constructed from sequences of the TOSV isolate ob-
tained from GenBank (Figure 2) using a maximum parsi-
mony analysis based on the alignment of the L TOSV
segment. The tree showed that the Tunisian sample se-
quences were clustered in four groups. One group included
7 sequences – 5 derived from the CSF sample and 2 from
sandly pools – showed that significant similarities exist
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Table 1 Sampling regions, number of tested and TOSV infected female’s sandflies
Region (Bioclimatic zone) Collected species Tested species (No.of sandflies tested/No. of pools) No of positive pools
Bizerte (Sub-humid) P. perniciosus P. perniciosus (75/3) 3
P. longicuspis P. longicuspis (25/1) 0
P. papatasi P. papatasi (25/1) 0
P. perfiliewi P. perfiliewi (50/2) 1
Tunis (Semi arid) P. perniciosus P. perniciosus (75/3) 2
P. papatasi P. papatasi (25/1) 0
P. perfiliewi P. perfiliewi (25/1) 0
S. minuta parroti S. minuta parroti (25/1) 0
Beja (Sub-humid) S. minuta parroti P. perniciosus* (75/3) 2
P. perniciosus
P. perfiliewi
P. papatasi P. perfiliewi (25/1) 1
S. fallax
S. antennata P. papatasi (50/2) 0
S.dreyfussi
Jendouba (Arid) P. papatasi P. papatasi (30/1) 0
P. perniciosus P. perniciosus (28/1) 0
P. longicuspis P. longicuspis (27/1) 0
S. minuta parroti
Monastir (Semi arid) P. perniciosus P. perniciosus (30/1) 1
P. papatasi P. papatasi (60/2) 0
P. perfiliewi P. perfiliewi (30/1) 1







Mahdia (Semi arid) P. perniciosus P. perniciosus (30/1) 0
P. papatasi
P. perfiliewi P. papatasi (30/1) 0
S. minuta parroti
P. longicuspis P. perfiliewi (30/1) 0
P. langeroni
S. dreyfussi S. minuta parroti (30/1) 0
Pa. alexandri
S. antennata S. antennata (30/1) 0
P. ariasi
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among the TOSV-isolated sequences described in France
[GenBank: KC700343, DQ975233], in Italy [GenBank:
X68414], and in Tunisia [GenBank: JX867537]. A second
group (18 sequences) shows significant similarities with the
TOSV Morocco isolate [GenBank: JN832571]. The third
group contains a single sequence [DDJB: AB905362] de-
rived from the sandfly pool and shows significant similar-
ities with the Punique sequences described in Tunisia
[GenBank: JF920133]. The fourth group contains a single
sequence [DDJB: AB905361] derived from a SFC sample
[DDJB: AB905361] and shows similarities with the SFSV
isolated in Algeria (Figure 2).
Discussion
The clinical manifestations of the TOSV infection are
the same as those provoked by several other neurotropic
viral agents, and require a rapid, sensitive laboratory
diagnosis for confirmation. Serological techniques such
as ELISA are useful for assaying specific IgM as a
marker of an acute infection. In this study, a serological
investigation for the TOSV infection was performed
(in house-ELISA) on 263 samples that included sera
(n = 191) and cerebrospinal fluids (n = 72) collected from
patients with AMM from different regions of Tunisia.
TOSV infection was recorded in 12.1% of the patients af-
fected by meningitis during the summer, since anti-
TOSV IgM were detected. IgG antibodies against TOSV
were detected in 78.1% of the IgM-positive cases. The
remaining 21.9% of IgM positive but IgG negative cases
could reflect a very early phase of infection. Similar re-
sults were observed in Turkey where IgG and IgM anti-
bodies were reactive with TOSV in 10.4% and 8.2% of the
sera respectively, while only 4% were reactive for both
IgG and IgM [28]. The detection of IgM, IgG or both,
can be achieved in cells infected with TOSV. However, it
is known that cross-reactivity exists between members
of the Phlebovirus genus and specifically between TOSV
and other serotypes of the Sandfly fever Naples ser-
ogroup [29,30]. The interpretation of serological assay re-
sults in the Mediterranean region, which is endemic for
several phleboviruses, may therefore be more difficult be-
cause of frequent recent infections and/or reinfections
that boost immunity. However, ELISA or IFA tests can be
used for screening purposes, but equivocal evaluations
might require retesting and/or confirmation [31]. Despite
the lack of confirmation by a seroneutralisation test, a
total of 32 patients with IgM positive and with evocative
symptoms are considered in this study to be probable
cases of acute TOSV infection.
The overall 12.1% TOSV seroprevalence rate is quite
similar to the rate observed in Tunisia by Bahri et al.
[21], who attributed 10% of seasonal meningitis cases be-
tween 2003 and 2009 to TOSV. This rate resembles that
recorded in Ankara, Turkey (11.2%) in patients with
aseptic meningoencephalitis [32]. However, this rate is
higher than that reported in Portugal (4.2%) in patients
with neurological symptoms [33]. Analyzing healthy people
from different bioclimatic zones of Tunisia [22] showed a
Table 1 Sampling regions, number of tested and TOSV infected female’s sandflies (Continued)
S.fallax P. perfiliewi (60/2) 2
S.christophersi
P. longicuspis









Tataouine (Saharan) P. papatasi P. papatasi (25/1) 0
P. perniciosus
P. longicuspis
S. minuta parroti P. longicuspis (25/1) 0
Pa. chabaudi
Total 14 1050/39 13
*One pool of P. pernicious PCR positive for Punique Virus.
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Figure 2 Phylogenetic analysis of the L segment of Toscana virus (TOSV) isolates from Human CSF (Filled circle) and pools of sandflies
(Filled square) collected in Tunisia, and homologous sequences of other selected TOSV stains. Sequences are identified by DDBJ accession
number, and strain name.
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9.5% seroprevalence for TOSV. Recently, Sakhria et al.
[34] recorded that the TOSV seroprevalence in Tunisia
varied from 17.2% to 59.4% depending on the region.
These observations emphasize the presence of asymp-
tomatic infections related to TOSV in exposed individ-
uals in Tunisia. The data confirm that TOSV infections
can produce mild influenza-like or subclinical infec-
tions, since TOSV causes severe illness involving the
central nervous system in only a few patients [8]. Several
serological surveys have shown that TOSV is endemic in
the Mediterranean Basin and that its seroprevalence var-
ies with the region: 80% in Italy, 17.8% in Turkey and
25% in Spain [3,18,28].
Despite the limitation of serological tests, viral RNA
detection has been established as a powerful tool and an
effective alternative for identifying acute TOSV infec-
tions [3,31]. This study indicates that among the CSF
(n = 140) samples analyzed by RT-PCR, 12.8% tested
positive for TOSV. Finding 18 cases of acute aseptic men-
ingitis due to TOSV among patients from different regions
in Tunisia confirms, for the first time, that TOSV is in-
volved in this neurological disease in North Africa. The in-
cidence of involvement resembles that observed in other
Mediterranean Basin countries [32,34-36].
With respect to the samples tested by serological and
molecular techniques (72 of 140), the discrepancies in
the results observed using these two diagnostic methods
can be explained either by assays’ different sensitivities
or by the timing of drawing CSF samples. Similar finding
were reported in Anatolia, Turkey where TOSV IgM was
identified via indirect immunofluorescence test in only
four of the 16 TOSV RNA positive samples [37].
The PCR amplicons were directly sequenced to con-
firm the TOSV genome and, possibly, to identify the
viral strain circulating in Tunisia. However, due to the
short sequences obtained with the primers Atos2 and
NPhlebo2+ (126bp), we could not identify the strain of
TOSV precisely.
Nevertheless, the sequences obtained correspond to
those described in Morocco [20], France [15,38] and
Tunisia [23]. In Morocco, only the lineage B was de-
scribed [20] whereas in France, the Italian lineage A and
the Spanish lineage B co-circulate [38].
In this study, using RT-PCR, we also identified the
presence of SFSV in the CSF sample of one febrile pa-
tient with meningoencephalitis from the Sousse region,
situated in the lower semi-arid bioclimatic zone. SFSV
have infrequently been implicated in central nervous
system infections. However, the presence of symptoms
and the detection of viral RNA confirmed that the Sousse
patient suffered from an acute infection with SFSV from
which he completely recovered. Similar cases of SFSV in-
fection were described in a patient returning from vacation
in Tunisia who was suffering from fever, headache, rigor,
nausea, joint pains and a maculopapular [39]. In addition,
sporadic cases from Turkey caused by this virus or a SFS-
like virus were described [30,40].
In earlier serological studies conducted in Tunisia,
neutralized antibodies against SFSV were detected in
1.3% of tested sera [41]. By using the Hemagglutination
Inhibition Test, 31% of sera collected from rodents, in-
sectivores, and chiropters in Tunisia were positive for
SFSV antibodies [42]. In addition, a new Sicilian-like
virus provisionally named the Punique virus was detected
in Laroussius flies in Utique, a city in northern Tunisia,
although no isolation was obtained [43].
The sandfly fauna of Tunisia includes 17 species [44]
whose density and diversity vary by bioclimatic zones.
Of these, the dominant P. papatasi, P. perniciosus and
P. perfiliewi are widespread in Tunisia where they trans-
mit leishmaniasis to dogs and humans [45]. Our results
show that they may also transmit TOSV. Indeed, RT-
PCR performed on pools of six species of Phlebotominae
trapped in northern Tunisia near the habitats of some
TOSV-positive patients showed that only P. perniciosus
and P. perfiliewi are TOSV-positive. This result corre-
lates with previous work demonstrating that these
species are the dominant arthropod TOSV vectors in
Italy, Morocco and Spain [2,20,46]. In addition, during
the course of this study, a peak of TOSV-related menin-
gitis and encephalitis occurred during the warm season,
which is the period of maximum activity of these sandfly
vectors [47].
In the effort to isolate the virus from Phlebotomine
pools by viral cultures, we isolated only the Punique
virus from one pool of P. perniciosus collected in Medjez
el Bab, located in the Beja governorate of Tunisia’s upper
semi arid bioclimatic zone. Recently described in Tunisia
by Zhioua et al. [43], this phlebovirus is closely related
to the Massilia virus but is largely different from other
viruses (Naples, Toscana, Tehran, and Algeria viruses) in
the SFV complex. The public health significance of the
Punique virus is unknown at this time. However, given
that its presence in Tunisia was confirmed despite any
correlation with clinical manifestations, this new viral
agent warrants further extensive research.
Conclusions
Several unexplained cases of meningitis recorded every
summer in Tunisian hospitals are confirmed as being
due to TOSV. A sporadic case is attributed to SFSV. In-
deed, the RNA of these viruses was detected in CSF
from patients with neurological symptoms and in sandfly
vectors (P. perniciosus and P. perfiliewi). Global changes,
including climate change, land use changes and mainly
livestock development, may influence the density and fu-
ture distribution of sandfly species. This may, in turn,
have implications for the epidemiology of sandfly-borne
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Phleboviruses and create new risk areas and potential
at-risk human populations. Consequently, surveillance pro-
grams should be designed to prevent the spread of sand-
flies in Tunisia.
TOSV should be considered an emergent viral patho-
gen that threatens healthy populations in Tunisia by
causing seasonal aseptic meningitis. Clinicians should be
aware of the role of TOSV and other Phleboviruses in
cases of meningitis and RT-PCR should be considered a
useful tool for their identification in clinical samples.
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